{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:01:09Z","timestamp":1784649669793,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jiph.2020.12.033","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:35:08Z","timestamp":1612658108000},"page":"533-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Antimicrobial and cytotoxic activities of isoniazid connected menthone derivatives and their investigation of clinical pathogens causing infectious disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Fatimah S.","family":"Al-Khattaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunadevi","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9623-3110","authenticated-orcid":false,"given":"Ashraf","family":"Atef Hatamleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-6274","authenticated-orcid":false,"given":"Idhayadhulla","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2020.12.033_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic, Escherichia coli in developing countries:epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiph.2020.12.033_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjmed.2005.07.063","article-title":"Endemically acquired foodborne outbreak of enterotoxin-producing Escherichia coli serotype O169:H41","volume":"119","author":"Devasia","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jiph.2020.12.033_bib0015","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4269\/ajtmh.1974.23.586","article-title":"Treatment of amebic liver abscess with emetine hydrochloride, niridazole, and metronidazole A controlled clinical trial","volume":"23","author":"Datta","year":"1947","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiph.2020.12.033_bib0020","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bmcl.2007.01.090","article-title":"The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents","volume":"17","author":"Murphy","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jiph.2020.12.033_bib0025","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/carcin\/bgs283","article-title":"Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B","volume":"33","author":"Li","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jiph.2020.12.033_bib0030","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.bmc.2014.06.012","article-title":"Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in anti-tuberculosis drug discovery","volume":"22","author":"Kigondu","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.drudis.2016.10.008","article-title":"Drug repurposing by integrateddfcd mining and drug\u2013gene\u2013disease triangulation","volume":"22","author":"Sun","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jiph.2020.12.033_bib0040","article-title":"Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: a critical review","volume":"105","author":"Verma","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0045","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1016\/j.ejmech.2020.112832","article-title":"Antibacterial activities with the structure-activity relationship of coumarin derivatives, antibacterial activities with the structure-activity relationship of coumarin derivatives","volume":"207","author":"Qin","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejmech.2014.04.077","article-title":"Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity","volume":"81","author":"Filomena","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/med.21262","article-title":"Antituberculosis drug research: a critical overview","volume":"33","author":"Beena","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jiph.2020.12.033_bib0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2017.04.002","article-title":"Isoniazid derivatives and their anti-tubercular activity","volume":"133","author":"Gao","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1039\/C4MD00288A","article-title":"Novel isoniazid\u2013 amidoether derivatives: synthesis, characterization and antimycobacterial activity evaluation","volume":"6","author":"Kumar","year":"2015","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.jiph.2020.12.033_bib0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmech.2014.05.005","article-title":"Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation","volume":"81","author":"Kumar","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0075","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00044-011-9705-2","article-title":"Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of isonicotinic acid-1-(substituted phenyl)- ethylidene\/cyclohepty lidene hydrazides","volume":"21","author":"Judge","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.jiph.2020.12.033_bib0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0085","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","article-title":"Biological activities of hydrazone derivatives","volume":"12","author":"Rollas","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.jiph.2020.12.033_bib0090","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejmech.2010.02.006","article-title":"Synthesis and antimicrobial activity of cholic acid hydrazone analogues","volume":"45","author":"Rasras","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/molecules16010016","article-title":"Novel synthesis of hydrazide-hydrazone derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thiophene derivatives with antitumor activity","volume":"16","author":"Mohareb","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.jiph.2020.12.033_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14419\/ijac.v2i2.2301","article-title":"Pharmacologically potentials of hydrazonone containing compounds A promising scaffold","volume":"2","author":"Asif","year":"2014","journal-title":"Int J Adv Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111804","article-title":"Structure-activity relationships (SAR) of triazine derivatives: promising antimicrobial agents","volume":"185","author":"Liu","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0110","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.bmcl.2005.03.065","article-title":"In vitro advanced antimycobacterial screening of isoniazid- related hydrazones, hydrazides and cyanoboranes: part 14","volume":"15","author":"Maccari","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.jiph.2020.12.033_bib0115","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4081\/idr.2012.e13","article-title":"In vitro anti-mycobacterial activity of (E)-N\u2019-(monosubstituted-benzylidene) isonicotino hydrazide derivatives against isoniazid-resistant strains","volume":"4","author":"Tatiane","year":"2012","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.jiph.2020.12.033_bib0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00044-013-0632-2","article-title":"Synthesis and evaluation of isonicotinoyl hydrazone derivatives as antimycobacterial and anticancer agents","volume":"23","author":"Naveen Kumar","year":"2014","journal-title":"Med Chem Res"},{"key":"10.1016\/j.jiph.2020.12.033_bib0125","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1016\/j.ejmech.2011.09.054","article-title":"New series of isoniazid hydrazones linked with electron-withdrawing substituents","volume":"46","author":"Vav\u0159\u00edkov\u00e1","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/187152407781669143","article-title":"Synthesis and evaluation of Schiff bases for anticonvulsant and behavioral depressant properties","volume":"7","author":"Jain","year":"2007","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0135","first-page":"83","article-title":"Analgesic activity and hypnosis potentiation effect of (\u00b1) 3-menthone semicarbazone and thiosemicarbazone derivatives","volume":"51","author":"Mishra","year":"2001","journal-title":"Acta Pharm"},{"key":"10.1016\/j.jiph.2020.12.033_bib0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/1521-4184(200205)335:5<183::AID-ARDP183>3.0.CO;2-U","article-title":"Anti HIV activity of thiosemicarbazone and semicarbazone derivatives of (\u00b1) 3-menthone","volume":"5","author":"Mishra","year":"2002","journal-title":"Arch Pharm Pharm Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0145","article-title":"Amino acids conjugated quinazolinone-Schiff\u2019s bases as potential antimicrobial agents: synthesis, SAR and molecular docking studies","volume":"90","author":"Rakesha","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0150","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1164\/ajrccm.149.5.8173779","article-title":"Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention","volume":"149","author":"Bass","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiph.2020.12.033_bib0155","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1016\/j.bmc.2013.09.034","article-title":"Synthesis and anti-mycobacterial activity of isoniazid derivatives from renewable fatty acids","volume":"21","author":"Rodrigues","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0160","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2217\/fmb-2019-0085","article-title":"Novel isoniazid derivative as promising antituberculosis agent","volume":"15","author":"Galyna","year":"2020","journal-title":"Future Microbiology"},{"key":"10.1016\/j.jiph.2020.12.033_bib0165","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00044-011-9705-2","article-title":"Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of isonicotinic acid-1-(substituted phenyl)-ethylidene\/cyclo heptylidene hydrazides","volume":"21","author":"Judge","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.jiph.2020.12.033_bib0170","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/14786410701482244","article-title":"Composition and antifungal activity of the essential oil of Mentha cervina from Portugal, Natural Product Research Formerly","volume":"21","author":"Gon \u00c7alves","year":"2007","journal-title":"Nat Prod Lett"},{"key":"10.1016\/j.jiph.2020.12.033_bib0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.resmic.2017.12.005","article-title":"Antibiofilm activity of bioactive hop compounds humulone, lupulone and xanthohumol toward susceptible and resistant staphylococci","volume":"169","author":"Bogdanova","year":"2018","journal-title":"Res Microbiol"},{"key":"10.1016\/j.jiph.2020.12.033_bib0180","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1038\/s41598-018-26998-x","article-title":"Mohamed rational discovery of (+) (S) abscisic acid as a potential antifungal agent: a repurposing approach","volume":"8","author":"Khedr","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2020.12.033_bib0185","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bmc.2003.11.001","article-title":"In vitro study of some medicinally important Mannich bases derived from antitubercular agent","volume":"14","author":"Joshi","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0190","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.ejmech.2009.03.044","article-title":"Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety","volume":"44","author":"Sujith","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0195","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.bmc.2009.04.027","article-title":"Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacin","volume":"17","author":"Gamal El-Din","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a Gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jiph.2020.12.033_bib0205","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/nbt1196-1557","article-title":"The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid","volume":"14","author":"Deretic","year":"1994","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jiph.2020.12.033_bib0210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.279.5347.98","article-title":"Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis","volume":"279","author":"Rozwarski","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jiph.2020.12.033_bib0215","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00044-013-0693-2","article-title":"Design, synthesis, and evaluation of isoniazid derivatives acting as potent anti- inflammatory and anthelmintic agents via Betti reaction Ipsita Mohanram","volume":"23","author":"Meshram","year":"2014","journal-title":"Med Chem Res"},{"key":"10.1016\/j.jiph.2020.12.033_bib0220","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00044-011-9634-0","article-title":"Synthesis, characterization and antimicrobial evaluation of novel derivatives of isoniazid","volume":"21","author":"Malhotra","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.jiph.2020.12.033_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127434","article-title":"Novel isoniazid embedded triazole derivatives: synthesis, antitubercular and antimicrobial activity evaluation","volume":"30","author":"Patil","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jiph.2020.12.033_bib0230","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01841-18","article-title":"Bactericidal I. Activity involves electron transport chain perturbation","volume":"63","author":"Zeng","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2020.12.033_bib0235","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bmcl.2005.01.073","article-title":"Synthesis of isonicotinic acid N\u2032-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antitubercul osisagents","volume":"15","author":"Sinha","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jiph.2020.12.033_bib0240","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1016\/j.bmcl.2005.07.011","article-title":"Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones","volume":"15","author":"Sriram","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jiph.2020.12.033_bib0245","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.2147\/DDDT.S270896","article-title":"Synthesis, cytotoxic analysis, and molecular docking studies of tetrazole derivatives via N- Mannich base condensation as potential antimicrobials","volume":"14","author":"Hatamleh","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jiph.2020.12.033_bib0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2013.05.003","article-title":"Design and synthesis of biquinoloneeisoniazid hybrids as a new class of antitubercular and antimicrobial agents","volume":"65","author":"Jardosh","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0255","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00044-011-9662-9","article-title":"Isonicotinic acid hydrazide derivatives: synthesis, antimicrobial activity, and QSAR studies","volume":"21","author":"Judge","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.jiph.2020.12.033_bib0260","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/157340611794072689","article-title":"Menthone aryl acid hydrazones: a new class of anticonvulsants","volume":"7","author":"Jain","year":"2011","journal-title":"Med Chem"},{"key":"10.1016\/j.jiph.2020.12.033_bib0265","article-title":"Antimicrobial activity of isoniazid in conjugation with surface- modified magnetic nanoparticle against Mycobacterium tuberculosis and nonmycobacterial microorganisms","volume":"9","author":"Zargarnezhad","year":"2020","journal-title":"J Nanomater"},{"issue":"4","key":"10.1016\/j.jiph.2020.12.033_bib0270","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/10412905.2009.9700193","article-title":"Antimicrobial activities of essential oils of mint and peppermint as well as some of their main compounds","volume":"21","author":"Jirovetz","year":"2009","journal-title":"J Essent Oil Res"},{"key":"10.1016\/j.jiph.2020.12.033_bib0275","first-page":"827","article-title":"Inhibitory activity of isoniazide and ethionamide against Cryptococcus biofilms","volume":"11","author":"Rossana de","year":"2015","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.jiph.2020.12.033_bib0280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/22297928.2011.10648206","article-title":"Antimicrobial activity of the major isolates of mentha oil and derivatives of menthol","volume":"1","author":"Kumar","year":"2011","journal-title":"Anal Chem Lett"},{"key":"10.1016\/j.jiph.2020.12.033_bib0285","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/jsfa.4021","article-title":"Seasonal variation in content, chemical composition and antimicrobial and cytotoxic activities of essential oils from four Mentha species","volume":"90","author":"Hussain","year":"2010","journal-title":"J Sci Food Agric"},{"key":"10.1016\/j.jiph.2020.12.033_bib0290","first-page":"4638","article-title":"Design, synthesis, and structure-activity relationship study of coumarin benzimidazole hybrid as potent antibacterial and anticancer agents","volume":"1","author":"Holiyachi","year":"2016","journal-title":"Chem Select"},{"key":"10.1016\/j.jiph.2020.12.033_bib0295","first-page":"289","article-title":"Design, synthesis and characterization of novel molecules comprising benzothiazole and sulphonamide linked to substituted aryl group via azo link as potent antimicrobial agents","volume":"2","author":"Patel","year":"2012","journal-title":"Int J Drug Res Tech"},{"key":"10.1016\/j.jiph.2020.12.033_bib0300","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bioorg.2011.02.004","article-title":"Synthesis of sulfanilamide derivatives and investigation of in vitro inhibitory activities and antimicrobial and physical properties","volume":"39","author":"Turkmen","year":"2011","journal-title":"Bioorg Chem"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:08:35Z","timestamp":1761750515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034121000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1876034121000022"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2020.12.033","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial and cytotoxic activities of isoniazid connected menthone derivatives and their investigation of clinical pathogens causing infectious disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2020.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}